Johnson & Johnson in Collaboration with Apple Launch Heartline Study App in the US
Shots:
- The study will assess the Heartline study app on iPhone- the ECG app and irregular rhythm notification feature on Apple Watch in improving the health outcomes including reduction in risk of stroke with earlier detection of AFib
- The companies offer US adults aged ≥65yrs. having an iPhone 6s or later version to join the study by downloading the Heartline study app. The heartline study will assess people for 3yrs. which includes 2yrs. of active engagement & 1yrs. of additional data collection
- In the study- one group of patients will use the Heartline study app on their iPhone and other groups will use the study app in addition to obtaining an Apple Watch to use the ECG app and irregular rhythm notification feature. The Heartline Study app will identify any suspected AFib rhythms and notify users when that happens
Click here to read full press release/ article | Ref: PRNewswire | Image: Baaz
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com